These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15561279)

  • 41. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
    Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
    Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
    Tsunemi S; Iwasaki T; Kitano S; Imado T; Miyazawa K; Sano H
    Clin Immunol; 2010 Aug; 136(2):197-204. PubMed ID: 20421177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
    Ng KT; Man K; Ho JW; Sun CK; Lee TK; Zhao Y; Lo CM; Poon RT; Fan ST
    Int J Oncol; 2007 Feb; 30(2):375-80. PubMed ID: 17203219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
    Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
    Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
    [No Abstract]   [Full Text] [Related]  

  • 46. Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients.
    Böhler T; Schütz M; Budde K; Neumayer HH; Waiser J
    Int Immunopharmacol; 2007 Jan; 7(1):88-95. PubMed ID: 17161821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
    Cyster JG; Schwab SR
    Annu Rev Immunol; 2012; 30():69-94. PubMed ID: 22149932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FTY720 and lung tumor development.
    Salinas NR; Oshima CT; Cury PM; Cordeiro JA; Bueno V
    Int Immunopharmacol; 2009 Jun; 9(6):689-93. PubMed ID: 19146992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged administration of FTY720 does not cause renal toxicity in mice.
    Galvão VR; Ginoza M; Franco M; Burdmann EA; Bueno V
    Transplant Proc; 2005; 37(1):112-3. PubMed ID: 15808564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of FTY720 on apoptosis of smooth muscle cells.
    Böhler T; Guillebaud J; Etienne L; Canivet C; Kamar N; Rostaing L; Thiers JC; Galvani S; Augé N; Salvayre R; Nègre-Salvayre A; Thomsen M
    Transplant Proc; 2007 Oct; 39(8):2624-6. PubMed ID: 17954194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
    J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry.
    Takai K; Jojima K; Sakatoku J; Fukumoto T
    Clin Exp Immunol; 1990 Dec; 82(3):445-9. PubMed ID: 1702372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sphingosine 1-phosphate receptor modulator FTY720 suppresses rat experimental autoimmune prostatitis.
    Zhang ZY; Zug C; Schluesener HJ
    Scand J Immunol; 2011 Jun; 73(6):546-53. PubMed ID: 21323692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Surg Today; 2005; 35(8):662-7. PubMed ID: 16034547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FTY720 treatment in experimentally urethane-induced lung tumors.
    Lucas da Silva LB; Ribeiro DA; Cury PM; Cordeiro JA; Bueno V
    J Exp Ther Oncol; 2008; 7(1):9-15. PubMed ID: 18472638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporin and the rat thymus. An immunohistochemical study.
    Schuurman HJ; van Loveren H; Rozing J; van Dijk A; Loeber JG; Vos JG
    Thymus; 1990; 16(3-4):235-54. PubMed ID: 2293425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of combined treatment with FK506, FTY720, and ex vivo graft irradiation in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1.
    Sugito K; Uekusa S; Kawashima H; Masuko T; Furuya T; Konuma N; Ohashi K; Inoue M; Ikeda T; Koshinaga T
    Pediatr Transplant; 2010 Aug; 14(5):614-7. PubMed ID: 20214743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
    Song J; Ito T; Matsuda C; Miao G; Tanemura M; Nishida T; Nozawa M; Matsuda H; Sawa Y
    Clin Exp Immunol; 2006 Oct; 146(1):85-92. PubMed ID: 16968402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat.
    Popovic J; Kover KL; Moore WV
    Pediatr Diabetes; 2004 Mar; 5(1):3-9. PubMed ID: 15043683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.